News
States representing about 84% of Medicaid beneficiaries are participating in an initiative that enables the U.S. government ...
The Centers for Medicare and Medicaid Services (CMS) has selected 35 participants for its new, voluntary Cell and Gene ...
Sanofi has been granted a speedy review from the FDA for a gene therapy for geographic atrophy (GA), a complication of age-related macular degeneration (AMD), as it prepares to test it in a clinical ...
3h
Medindia on MSNGene Therapy Brings Back Hearing in Genetic DeafnessThis study marks the first time gene therapy has shown consistent success in both children and adults with OTOF-related ...
The gene therapy regimen seems to be working wonders, including restoring nearly all hearing to a seven-year-old patient after just four months.
Paris: Sanofi has received fast track designation from the US Food and Drug Administration (FDA) for SAR446597, a one-time ...
From Wall Street to real estate to a “big, ugly” pharma building, Mayo Venture Partner Audrey Greenberg reflects on a career ...
The brain is one of the body’s most energy-demanding organs, accounting for 2 percent of the body’s weight but consuming 20 ...
Nanoscope Therapeutics begins rolling submission of BLA to US FDA for gene-agnostic therapy, MCO-010 to treat retinitis pigmentosa: Dallas, Texas Wednesday, July 16, 2025, 14:30 H ...
Indian American chemist receives prestigious CAREER award for research on synthetic DNA ‘programmable’ nanoparticles ...
Danaher, a United States-headquartered life sciences conglomerate, announced a strategic partnership in Shanghai on Monday between its operating company Cytiva and CorrectSequence Therapeutics, a ...
Klotho Neurosciences Maintains Listing on the NASDAQ NEW YORK, July 16, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. ("Klotho" or the "Company") (NASDAQ: KLTO), a gene and cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results